Vascular Surgery Fellowship Director
Joseph Ricotta, M.D.
Vascular Surgery Fellowship Program Director
Dr. Joseph Ricotta is a nationally and internationally renowned expert in the field of Vascular and Endovascular Surgery. He brings years of valuable experience working at the nation’s leading institutions—such as Yale, Johns Hopkins, Mayo Clinic, and The Cleveland Clinic.
He is currently the National Director of Vascular Surgery and Endovascular Therapy at Tenet Healthcare as well as the Chairman of the Department of Vascular Surgery at Delray Medical Center and Professor of Surgery and Program Director of the Vascular Surgery Fellowship at the Charles E. Schmidt College of Medicine at Florida Atlantic University.
Dr. Ricotta completed his undergraduate degree at Yale University and received his medical degree from Jefferson Medical College. He went on to complete the Halsted General Surgery Residency at Johns Hopkins Hospital and was a traveling scholar and Specialist Registrar in Vascular Surgery at Oxford University in England. He also completed a Vascular and Endovascular Surgery Fellowship at the Mayo Clinic in Rochester, MN, followed by an Advanced Endovascular Surgery Fellowship at the world-renowned Cleveland Clinic.
Dr. Ricotta has garnered national and international recognition as an innovative pioneer and thought-leader in vascular surgery. He was the first surgeon in the United States—and is one of a few in the world—to perform endovascular robotic surgery using the Corindus Robot. He is the first surgeon in the United States with FDA IDE approval to create and implant custom modified endografts in high risk patients with complex aortic aneurysms, and was the first to perform peripheral drug coated balloon angioplasty in the state of Georgia. In addition, he is the first surgeon in the southeast United States to successfully perform the VenaSeal™ closure procedure, the newest treatment for varicose veins and venous insufficiency, and the first in South Florida to perform TCAR (Trans Carotid Artery Revascularization), the newest treatment for carotid disease and stroke.
Along with providing the entire spectrum of state-of-the-art vascular and endovascular clinical services, Dr. Ricotta has also authored over 200 publications, been an investigator in over 60 clinical research trials, and delivered over 300 lectures both on the national and international stage.
He serves on the Editorial Board for several professional medical publications and is the Co-Founder and Meeting Chair of the International Aortic Summit. Throughout his esteemed career, he has served on multiple committees for various surgical societies including the Society for Vascular Surgery and regularly serves as a consultant for a myriad of industrial corporations.
Dr. Ricotta has received numerous awards and has been repeatedly named a “Top Doctor” by U.S. News and World Report, as well as one of “America’s Top Doctors” by Castle Connolly, who only gives this designation to the top 1% of doctors in the nation. He has also been chosen as a “Top Surgeon” in the United States on multiple occasions, as one of "America's Most Honored Professionals" given to the Top 1% in the United States, and has been named a Distinguished Fellow by the Society for Vascular Surgery.
With his abundant experience and reputation as one of the best vascular surgeons in the nation, Dr. Ricotta is also dedicated to the training and teaching of future physicians and vascular surgeons. Through his positions as Professor of Surgery, Program Director of the Vascular Surgery Fellowship, and Site Director of the General Surgery Residency Program at Florida Atlantic University, he is very active in the training of medical students, physician assistant students, surgical residents, and vascular surgery fellows. He also leads a variety of training workshops on new and innovative endovascular techniques for physicians and vascular surgeons from all over the world.